GOLD looks back at some of the top news stories from the pharmaceutical industry over the last few months, covering regulatory approvals, governmental schemes and much more
Words by Jade Williams
29 April
New Astellas CEO acquires Iveric Bio, the largest acquisition in company’s history
16 May
First-of-its-kind non-hormonal menopause treatment wins FDA nod
3 June
FDA allows temporary import of chemotherapy drug cisplantin from Chinese manufacturer due to shortage
06 June
UK government launches £40m drug pilot to tackle obesity and ease pressure on NHS
19 June
Eurofarma takes top prize at Cannes with scrolling therapy app for Parkinson’s
28 June
AstraZeneca commits $400m to reforestation and biodiversity to support world health
05 July
Moderna announces intent to work towards mRNA R&D in China in potential £1bn investment
26 July
FDA approves Warfarin reversal drug that enables patients to undergo urgent surgery or invasive procedures
7 August
Biotech investment in the UK rises 29% in Q2 in comparison to Q1
9 August
AstraZeneca signs Swedish wind power deal with EU’s largest renewable energy provider
10 August
Novo Nordisk’s Wegovy sales cross the $1bn mark
16 August
UK Government allots £210m to reducing AMR in Africa and Asia
